FundedIQ
Artificial Intelligence

Scailyte: Funding, Investors & Team (Sep 2026)

Scailyte has developed a data-based platform for finding biomarkers, combining their expertise in analyzing individual cells' data and artificial intelligence. They are using this platform to uncover a fresh category of biomarkers that are characterized by the molecular makeup of cells linked to diseases. This method of biomarker discovery, focused on the observable characteristics of a disease, is innovative and greatly increases the chances of finding accurate and reliable biomarkers.

www.scailyte.com LinkedIn Basel, Switzerland 11-50 employees
Artificial Intelligence (AI) Biotechnology Health Care Health Diagnostics Medical Precision Medicine B2B
Total raised
$8.6M
Rounds
3
Latest
Series A
Dec 2023

Scailyte has raised $8.6M across 3 funding rounds on record, the most recent a Series A of $1.8M announced in Dec 2023.

That round is below the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.

Scailyte Company Profile and Key Stats

Total funding raised
$8.6M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Series A
$1.8M in Dec 2023
Employees
11-50
reported band
Headquarters
Basel, Switzerland

Latest funding round on record: Dec 2023.

Scailyte Funding Rounds

Date
Round
Amount
Series A
$1.8M
Series A
$6.2M
Undisclosed round
$600k

Scailyte raised $600k in an undisclosed round announced in Aug 2020.

2.1 years later, a Series A of $6.2M was announced in Sep 2022.

1.3 years later, a Series A of $1.8M was announced in Dec 2023.

Scailyte Founders and Leadership Team

Name
Role
Contact
Manfred Claassen
Founder
Peter Nestorov
CEO
Locked

Contact details for the Scailyte team: 1 of 2 have an email address on file.

Start 14-day free trial →

Scailyte Funding Compared to Other Artificial Intelligence Startups

Segment
Companies
Median round

Scailyte's latest round of $1.8M is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Scailyte in Artificial Intelligence and Basel

Companies Similar to Scailyte

At SUIND, our goal is to utilize advanced technology to enhance the productivity and ecological impact of…

Seed $2.1M

Established in 2018, Aktiia, now operating under the name Hilo, aims to revolutionize the measurement and…

Series B $19.0M

Anyway Systems is an IT company that develops AI deployment software for organizations.

Undisclosed round $120k

Rflect helps universities protect their business model in the age of AI by training the human skills machines…

Seed $1.2M

Computer Vision develops artificial intelligence software for medical imaging with a focus on radiology and…

Undisclosed round $880k

Expert in AI-generated multi-marker algorithms. First product launched (Software as Medical Device) to…

Series A $5.3M

Hephaistos develops AI-based systems to design new enzymes from scratch for use in chemical and industrial…

Undisclosed round $190k

AVIAN is an industrial AI business that creates temperature monitoring and predictive safety systems for…

Pre-Seed $2.5M

Gravit Open Network is a distributed infrastructure for epistemic execution and verifiable knowledge. It…

Seed $6.4M

Moonlight AI empowers pathologists and hematologists to make therapeutic decisions backed by genomic insight.…

Seed $3.3M

Newborns’ sounds of cries carry a wealth of information about their health, needs and emotions – including…

Undisclosed round $760k

KEMARO GmbH, headquartered in Eschlikon, Switzerland, was founded in August 2016 by three engineers…

Series B $5.0M

Scailyte Funding FAQs

What does Scailyte do?

Scailyte has developed a data-based platform for finding biomarkers, combining their expertise in analyzing individual cells' data and artificial intelligence. They are using this platform to uncover a fresh category of biomarkers that are characterized by the molecular makeup of cells linked to diseases. This method of biomarker discovery, focused on the observable characteristics of a disease, is innovative and greatly increases the chances of finding accurate and reliable biomarkers.

How much funding has Scailyte raised?

Scailyte has raised $8.6M across 3 rounds on record. The most recent is a Series A of $1.8M announced in Dec 2023.

When did Scailyte last raise funding?

Scailyte's most recent funding round on record is a Series A of $1.8M, announced in Dec 2023.

Who founded Scailyte?

FundedIQ lists Manfred Claassen (Founder) at Scailyte.

Who is the CEO of Scailyte?

Peter Nestorov is listed as CEO at Scailyte.

Where is Scailyte headquartered?

Scailyte is based in Basel, Basel-Stadt, Switzerland.

How many employees does Scailyte have?

Scailyte is in the 11-50 employee band.

How does Scailyte's funding compare to other Artificial Intelligence startups?

Scailyte's latest round of $1.8M is below the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.

About FundedIQ's Scailyte Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Scailyte is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.